Open Access

Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7

  • Bettina Wöchtl1,
  • Florian Gunzer2,
  • Wilhelm Gerner3,
  • Hagen Gasse4,
  • Michaela Koch1,
  • Zoltán Bagó5,
  • Martin Ganter6,
  • Herbert Weissenböck7,
  • Nora Dinhopl7,
  • Sina M. Coldewey8, 9,
  • Alexandra von Altrock6,
  • Karl-Heinz Waldmann6,
  • Armin Saalmüller3,
  • Kurt Zimmermann10,
  • Jörg Steinmann11,
  • Jan Kehrmann11,
  • Ludger Klein-Hitpass12,
  • Jochen Blom13,
  • Ralf Ehricht14,
  • Ines Engelmann14 and
  • Isabel Hennig-Pauka1Email authorView ORCID ID profile
Gut Pathogens20179:30

https://doi.org/10.1186/s13099-017-0179-8

Received: 16 February 2017

Accepted: 17 May 2017

Published: 25 May 2017

Abstract

Background

Shiga toxin (Stx) producing Escherichia coli (E. coli) (STEC) is the most frequent cause of diarrhoea-positive haemolytic uraemic syndrome (D + HUS) in humans. In 2011, a huge outbreak with an STEC O104:H4 strain in Germany highlighted the limited possibilities for causative treatment of this syndrome. The responsible STEC strain was found to combine Stx production with adherence mechanisms normally found in enteroaggregative E. coli (EAEC). Pathotypes of E. coli evolve and can exhibit different adhesion mechanisms. It has been shown previously that neonatal gnotobiotic piglets are susceptible for infection with STEC, such as STEC O157:H7 as well as for EAEC, which are considered to be the phylogenetic origin of E. coli O104:H4. This study was designed to characterise the host response to infection with the STEC O104:H4 outbreak strain in comparison to an STEC O157:H7 isolate by evaluating clinical parameters (scoring) and markers of organ dysfunction (biochemistry), as well as immunological (flow cytometry, assessment of cytokines/chemokines and acute phase proteins) and histological alterations (light- and electron microscopy) in a gnotobiotic piglet model of haemolytic uraemic syndrome.

Results

We observed severe clinical symptoms, such as diarrhoea, dehydration and neurological disorders as well as attaching-and-effacing lesions (A/E) in the colon in STEC O157:H7 infected piglets. In contrast, STEC O104:H4 challenged animals exhibited only mild clinical symptoms including diarrhoea and dehydration and HUS-specific/severe histopathological, haematological and biochemical alterations were only inconsistently presented by individual piglets. A specific adherence phenotype of STEC O104:H4 could not be observed. Flow cytometric analyses of lymphocytes derived from infected animals revealed an increase of natural killer cells (NK cells) during the course of infection revealing a potential role of this subset in the anti-bacterial activity in STEC disease.

Conclusions

Unexpectedly, E. coli O104:H4 infection caused only mild symptoms and minor changes in histology and blood parameters in piglets. Outcome of the infection trial does not reflect E. coli O104:H4 associated human disease as observed during the outbreak in 2011. The potential role of cells of the innate immune system for STEC related disease pathogenesis should be further elucidated.

Keywords

Swine Gnotobiotic piglets Enteroaggregative E. coli Enterohaemmorrhagic E. coli Shiga toxin Haemolytic uraemic syndrome (HUS) E. coli O104:H4 E. coli O157:H7

Background

Shiga toxin (Stx) producing Escherichia coli (E. coli) (STEC) is a frequent cause of D + HUS in humans. HUS is characterized by acute renal failure, haemolytic anaemia and thrombocytopenia [1]. In 2011 an outbreak of STEC O104:H4 associated disease occurred in Germany. In total, 3816 clinical cases and the death of 54 persons were reported between May 1st and July 4th. In contrast to the epidemiological course of disease in outbreaks due to classical EHEC infections, the percentage of patients suffering from HUS was high (22%) and most of the HUS patients were female adults and not children [2].

Attaching and effacing (A/E) lesions in the gut are a hallmark for EHEC infection. The genes involved in A/E mechanisms are located on the locus of enterocyte effacement (LEE) that contains, amongst others, the eae gene encoding intimin. As various alternative adhesion mechanisms have been described in STEC so far, the terms STEC and EHEC should not be used synonymously [3]. All STEC including EHEC have in common that they produce one or more Stxs in the intestine [3]. Globotriaosylceramide (Gb3)-dependent internalisation of Stxs into sensitive cells has been demonstrated [4]. Previously, an alternative mechanism could be shown. Stx produced by EHEC O157:H7 [5] and E. coli O104:H4 [6] can be released by outer membrane vesicles (OMV). Subsequent, OMVs and their contents can be internalised to human intestinal epithelial cells (IEC) [6].

The outbreak strain of 2011 produced Stx2a, extended-spectrum beta-lactamases (ESBL) and exhibited the adherence mechanism of EAEC [2]. E. coli O104:H4 is considered an emerging pathogen endowed with virulence factors from different strains. Up to now, a conclusive explanation for the severity of the outbreak and the clinical and epidemiological differences compared to other and better known STEC strains of enteropathogenic E. coli (EPEC) origin is lacking. It was previously hypothesised that the different adherence mechanisms of E. coli O104:H4 may be the reason for the severity of the outbreak [79]. Another explanation may be that specific virulence factors of the strain facilitate disruption of the epithelial barrier and Stx-transfer to circulation [9]. Amongst others, three serine protease autotransporters produced by E. coli O104:H4 may contribute to an increase in Stx intake [10].

Understanding pathogenesis of HUS is the prerequisite for the development of new preventive and therapeutic strategies for this syndrome. While many bacterial characteristics have been elucidated so far, knowledge about the hosts innate and adaptive immune reactions as well as genetically determined susceptibility and co-factors for disease is fragmentary. Recently, the decisive role of natural killer T cells (NKT) for Stx2-induced pathology was shown in mice [11]. Stx2-binding to Gb3 led to an aberrant CD1d-mediated NKT cell activation in podocytes and glomerular endothelial cells expressing the CD1d molecule. It was assumed that Stx2-induced co-stimulatory molecules in renal cells led to NKT cell activation [11].

Various animal models are used to investigate aspects of pathogenesis in STEC associated disease [1216]. Gnotobiotic piglets infected with Stx-producing E. coli O157:H7 and E. coli O26:H11 developed clinical and pathological features of HUS, which qualified the model for reproduction of human STEC-related disease [15]. Neonatal gnotobiotic piglets were also successfully used for EAEC infection experiments [17]. Based on these former experiences, the gnotobiotic piglet model was assessed for parallel infection experiments with E. coli O104:H4 and EHEC O157:H7. An infection model described previously [15] was adapted with only slight modifications.

The aim of this study was to compare clinical outcome and underlying pathological mechanisms of infection with LEE-negative E. coli O104:H4 and LEE-positive E. coli O157:H7 employing a gnotobiotic piglet model of HUS by using oral infection with these strains. Specifically, we assessed over the course of the experiment haematological and biochemical parameters indicating STEC-related disease in humans and we compared the colonisation characteristics of both strains in the porcine intestine by electron microscopy and bacteriological examination. Furthermore, we tested in vivo Stx production in the intestine by performing Stx ELISA from stool samples. Immunological analyses, such as phenotyping of peripheral blood mononuclear cells (PBMCs) and lymphocytes from mesenterial and ileocaecal lymph nodes by flow cytometry were executed to address the open question, which cell populations may be of importance in STEC disease. Circulating cytokines/chemokines were determined by using fluorescent microsphere immunoassays (FMIA).

Methods

Delivery and infection experiments in gnotobiotic piglets

Gnotobiotic piglets were derived from four German Landrace sows by Caesarian section in three consecutive trials as described previously [15]. During the trial, sterility was tested by regular bacteriological examination of swabs from the animals and the isolators at the end of the experiment.

In total, 55 piglets were delivered from the four sows. For this study, data of 13 piglets belonging to three different experimental groups were included into evaluation: control group (n = 3) and infection groups E. coli O104:H4 (n = 6) and E. coli O157:H7 (n = 4), respectively. All other piglets were of low vitality, did not stay sterile or had been used for other experiments.

Piglets were infected orally 12 h after birth with 5 ml bacterial suspension using a curved olive headed probe outreaching the root of tongue. The control group received sterile sodium chloride (0.9% NaCl) (Table 1).
Table 1

Infective dose administered, bacteriological and clinical findings in individual animals

Group animal number

Infective dose (CFUs)

CFUs/g stool day 4 p.i.

CFUs/g stool day 5–6 p.i.

OD Stx ELISA day 5–6 p.i.

CFUs/g stool day 9–12 p.i.

OD Stx ELISA day 9–12 p.i.

Average clinical score (animal/group)

Clinical signs, assessed at least once

Day of death

Negative

 1

Mock

Sterile

Sterile

n.a.

Sterile

0.009 (N)

0.00

None

10

 2

Mock

Sterile

Sterile

0.025 (N)

Sterile

0.012 (N)

0.11

Reduced appetite

9

 3

Mock

Sterile

Sterile

0.020 (N)

  

0.00

None

6a

       

Ø 0.04

  

E. coli O104:H4

 4

1.00 × 109

1.22 × 1010

2.81 × 1010

n.a.

8.60 × 108

4.538 (P)

0.53

Reduced appetite, dehydration

10

 5

1.00 × 109

8.17 × 109

6.88 × 1010

n.a.

2.62 × 109

3.993 (P)

0.51

Reduced appetite, dehydration, mild central nerval signs

10

 6

2.19 × 108

2.13 × 1010

3.38 × 107

n.a.

Sterile

2.746 (P)

0.46

Reduced appetite, dehydration

10

 7

2.19 × 108

1.18 × 107

2.10 × 109

n.a.

Sterile

3.492 (P)

0.52

Reduced appetite, mild central nerval signs

9

 8

2.19 × 108

3.13 × 109

1.63 × 109

4.122 (P)

  

0.07

Reduced appetite

6a

 9

2.19 × 108

5.58 × 109

1.11 × 1010

2.833 (P)

4.65 × 107

4.561 (P)

0.11

Reduced appetite, dehydration

12

       

Ø 0.37

  

E. coli O157:H7

 10

2.20 × 108

5.43 × 109

 

.

  

0.74

Severe neurological signs

4b

 11

2.20 × 108

1.02 × 1010

8.35 × 109

n.a.

5.95 × 109

4.599 (P)

0.67

Mild central nerval signs, dehydration

11

 12

2.08 × 108

1.95 × 107

2.50 × 107

4.358 (P)

  

0.30

Severe neurological signs

5b

 13

2.08 × 108

1.30 × 109

1.37 × 108

4.527 (P)

  

0.50

Dehydration

5b

       

Ø 0.55

  

Interpretation Shiga toxin ELISA: optical density (OD) < 0.070 = negative; OD > 0.070/<0.100 = indefinite, ODs > 0.100 = positive

n.a. not assessed, N negative, P positive

aEuthanized early due to organisational reasons

bEuthanized early due to severe clinical symptoms

Bacterial strains

Escherichia coli O157:H7 strain 86-24 originates from a meat associated EHEC outbreak in Walla Walla WA [18]. This intimin positive strain has an A/E phenotype, synthesizes Stx2 and is able to cause a D + HUS like disease in gnotobiotic piglets [15].

Escherichia coli O104:H4 strain e2975 is a stool isolate obtained from a 16-year-old male patient, who was admitted to the University Hospital Essen, Essen, Germany with bloody diarrhoea during the 2011 EHEC outbreak in Germany. In the further course the patient developed HUS and also exhibited seizures. The strain was geno-serotyped using the E. coli PanType AS-2 DNA oligonucleotide microarray [19] from Alere Technologies (Jena, Germany). Stx subtyping was performed with the ShigaToxType AS-2 from Alere Technologies [20]. Furthermore, the complete genome of the strain was determined on an Illumina HiSeq sequencing system (Illumina, San Diego, CA, USA). Like all isolates of that outbreak, it bears the serotype O104:H4 and is a chimera between EHEC and EAEC. It displays a blended phenotype with characteristics of both E. coli pathotypes [7, 21, 22]. The strain produces Stx2 variant a, lacks intimin and enterohemolysin, is positive for iha encoding an adherence-conferring protein homologous to IrgA [23] and shows an ESBL resistance pattern due to plasmid encoded TEM-1 and CTX-M-M15 β-lactamases. It also possesses mchB coding for the microcin H47 activity protein [24].

Escherichia coli cultures for oral infection were prepared in advance and stored in 0.9% NaCl at room temperature. Briefly, 4 ml overnight culture of the respective bacterial strain were grown in LB broth (LBB; 10 g/l tryptone, 10 g/l NaCl, 5 g/l yeast extract) and inoculated at an optical density OD600 of 0.06 in 100 ml LBB the following day. When a specific OD600 was reached, individually determined for each strain according to growth curves, bacteria were harvested by centrifugation (50 ml tubes, 4000×g at 4 °C for 10 min). The supernatant was discarded and the pellet was washed once with phosphate buffered saline (PBS; 1.4 mM NaCl, 116 mM NaH2PO4, 18 mM KH2PO4) to remove any free Stx or degradation products. Cultures were diluted in 0.9% NaCl and colony forming units (CFU) were determined by plating and counting serial dilutions. Bacterial suspensions were stored at room temperature until further use. Piglets were orally infected with 5 ml liquid culture with doses ranging from 2.08 × 108 to 2.20 × 108 CFU for E. coli O157:H7 and 2.19 × 108 to 1.00 × 109 CFU for the E. coli O104:H4 outbreak strain.

Clinical and laboratory diagnostic monitoring

A visual inspection of animals was performed every 2 h and clinical scores were recorded every 4 h. Appetite, neurological signs and status of hydration were separately assessed as physiological (score 0), mild (score 1) and severe (2) and scores were added to calculate a total score. A total clinical score for each individual was generated by dividing sum of all scores through number of examination time points.

If clinical scores were assessed to be ≥2 at two consecutive examination times the respective pig was euthanised due to animal welfare reasons. The experiment was finalised on days 9–12 after infection by euthanasia of piglets (Table 1). Immediately after death, pigs were removed from the isolator, weighed and dissected under a S2 laminar air flow workbench.

Blood was sampled from the Vena cava cranialis immediately prior to infection (day 0), on day 6 after infection and prior to euthanasia at the end of the experiment. Urine samples were taken on day 6 after infection and prior to euthanasia. Faeces samples were collected prior to infection, on days 4 and 6 and after euthanasia.

Red and white blood cells as well as clinical chemistry parameters were determined according to routine diagnostic methods described elsewhere with slight modifications [25]. Acute phase proteins haptoglobin (Tridelta Phase Haptoglobin Assay, Tridelta Development Limited, Maynooth, Ireland), C-reactive protein (Phase Porcine CRP Assay, Tridelta Development Limited) and lipopolysaccharide-binding proteins (LBP ELISA, Hycult Biotech, Uden, Netherlands) were determined according to the manufacturer’s instructions of used detection kits.

Urine was collected on day 6 and day of death and processed for routine diagnostics, including refractometry, urine chemistry and testing by Combur 9 test strips (Roche Diagnostics, Mannheim, Germany). In sediments the amount of bacteria, leukocytes, superficial squamous epithelial cells, round epithelial cells and deeper transitional epithelial cells as well as crystals were assessed by microscopical inspection. The glomerular filtration rate (GFR) and the fractional excretions (FE) of water and Na were calculated based on the endogenous marker creatinine, which is exclusively eliminated by glomerular filtration [26].

During necropsy organ tissue samples from all parenchymatous organs, gastro intestinal tract and brain were collected for histological examination. Tissue from Colon ascendens, cerebellum and kidney were sampled for electron microscopy (EM).

Faecal samples were obtained on day 4, 6 and day of necropsy. A 1:10 starting solution was prepared by dissolving 100 mg faeces in 900 µl PBS and was then diluted further up to 10−8. 10 µl of each serial dilution were spotted clockwise on Müller-Hinton agar (Oxoid, Thermo Fisher Scientific, Wesel, Germany), sorbitol MacConkey agar (SMAC, Oxoid) and CHROMagar ESBL (MAST DIAGNOSTICA, Reinfeld, Germany) in parallel to obtain a general overview of the bacterial load in the fecal samples. For detailed analysis 50 µl of bacterial suspension were spread on an entire agar plate.

After incubation for 18 h at 37 °C, CFU/g faeces were calculated from bacterial counts obtained with appropriate agar plates of the dilution series. Semiquantitative determination of Stx2 in faecal samples was carried out using the ProSpecT Shiga Toxin E. coli (STEC) Microplate Assay (Oxoid) according to the manufacturer´s instructions.

Light and electron microscopy

All tissue samples were fixed and stained according to routine histological methods as described previously [27]. After immediate fixation in 10% buffered formalin samples were embedded in paraffin wax. Paraffin sections (6 µm) were either stained with hematoxylin–eosin (HE, hemalaun after Delafield) or with Masson´s trichrome stain for routine histological examination.

Multiple small 1 mm3 tissue blocks from the renal cortex, the colonic mucosa, and the cerebellum were sampled for electron microscopy and fixed in 5% glutaraldehyde in phosphate-buffered saline (PBS). After an adequate fixation time of at least 24 h samples were washed in PBS, postfixed for 90 min in 1% osmium tetroxide in double-distilled water, subsequently rinsed in 30, 50 and 70% ethanol. In a next step tissue was infiltrated with uranylacetate and phosphoric tungstic acid within 2 h. After subsequent 60-min-treatments with 90% ethanol, 100% ethanol and propylene oxid, tissue was stored in epon (Epon 812, Fluka, Buchs, Switzerland): propylene oxid in a 1:1 mixture at 4 °C overnight. The next day samples were infiltrated with pure epon for 1 h and poured in silicon forms, followed by two 24-h-polymerization steps at 35 and 45 °C and one 60-h-polymerization step at 60 °C. Toluidine blue stained thin sections (1.5 μm) from each tissue block were inspected for selection of areas for EM ultrathin sectioning. Ultrathin sections were cut on a Leica Ultramicrotome (Leica Ultracut S, Vienna, Austria) and stained with uranyl acetate (Sigma-Aldrich, Vienna, Austria) and lead citrate (Merck, Darmstadt, Germany). Ultrathin sections were examined with a Zeiss TEM 900 electron microscope (Carl Zeiss, Oberkochen, Germany) operated at 50 kV.

Isolation and phenotyping of lymphocytes and myeloid cells

In accordance with a previously established protocol [28], PBMCs were isolated from heparinized blood by density gradient centrifugation using lymphocyte separation medium (Pancoll human, density 1.077 g/ml, PAN Biotech, Aidenbach, Germany), which had been adjusted by PBS (without Ca2+ and Mg2+, PAN Biotech) dilution to a density of 1.075 g/ml. Mesenterial and ileocaecal lymph nodes were dissected during necropsy from surrounding tissue, pooled for each individual animal and further processed as described elsewhere [29].

Isolated cells from blood and lymph nodes were suspended in PBS supplemented with 10% porcine plasma (in-house preparation). Cell labelling was performed in 96-well round-bottom microtiter plates (Greiner Bio One, Frickenhausen, Germany) with 2 to 5 × 105 cells per sample. Antibodies and second-step reagents used for labelling are listed in Table 2. Prior to use, optimal working dilutions for all antibodies and second-step reagents had been determined in titration experiments. Mastermixes of antibodies were prepared freshly before use. After addition of primary antibodies samples were incubated for 20 min at 4 °C, followed by two washing steps in 200 μl of PBS. A plate shaker was used for resuspension of cells after washing steps. Secondary reagents were added and also incubated for 20 min at 4 °C, followed by two washings steps with PBS + 10% porcine plasma. For discrimination of dead cells Fixable Near-IR Dead Cell Stain Kit (Invitrogen, Carlsbad, CA, USA) was used during the second incubation according to manufacturer’s instructions. In a further incubation step fixation and permeabilization was performed with the BD Cytofix/Cytoperm kit (BD Biosciences, San Jose, CA, USA) according to the manufacturer`s instructions. This allowed the staining of the intracellular epitope recognized by the anti-CD79α antibody (Table 2).
Table 2

Antibody panels used for immunophenotyping by flow cytometry

Cell population addressed

Antigen

Clone

Isotype

Fluorochrome

Labelling strategy

Source of primary Ab

Myeloid cells, B cells and CD4+ T cells

CD3

PPT3

IgG1

BV 421a

Biotin–streptavidin

In-house

CD79α

HM57

IgG1

PE

Direct conjugation

Dako

 

CD172α

74-22-15

IgG1

Alexa Fluor 647b

Direct conjugation

In-house

CD4

74-12-4

IgG2b

Alexa 488c

Secondary antibody

In-house

T cells and NK-cell subpopulations

CD3

PPT3

IgG1

BV 421a

Biotin–streptavidin

In-house

CD4

74-12-4

IgG2b

Alexa Fluor 488c

Secondary antibody

In-house

CD8α

11/295/33

IgG2a

PEd

Secondary antibody

In-house

NKp46

VIV-KM1

IgG1

Alexa Fluor 647b

Direct conjugation

In-house

γδ T-cell subpopulations

TCR-γδ

PPT16

IgG2b

BV421a

Biotin–streptavidin

In-house

CD8α

11/295/33

IgG2a

Alexa Fluor 647b

Direct conjugation

In-house

CD27

b30c7

IgG1

PEe

Secondary antibody

In-house

CD2

MSA4

IgG2a

Alexa Fluor 488f

Direct conjugation

In-house

aBrilliant Violet 421 streptavidin, BioLegend, San Diego, CA, USA

bAlexa Fluor 647 Protein Labelling Kit, Invitrogen, Carlsbad, CA, USA

cGoat anti-Mouse IgG2b-Alexa Fluor 488, Invitrogen, Carlsbad, CA, USA

dGoat anti-Mouse IgG2a-PE, Southern Biotech, Birmingham, AL, USA

eGoat anti-Mouse IgG1-PE, Southern Biotech, Birmingham, AL, USA

fAlexa Fluor 488 Protein Labelling Kit, Invitrogen, Carlsbad, CA, USA

For each fluorochrome single stain samples were prepared at the time when the staining protocol was established and used for automatic calculation of compensation by FACSDiva software Version 6.1.3 (BD Biosciences).

Samples were analysed on a BD FACSCanto II flow cytometer equipped with a high-throughput sampler and three lasers (405, 488 and 633 nm, BD Biosciences) and subsequently analysed by FACSDiva software (Fig. 1). In PBMC numbers of analysed cells ranged from 12,000 to 132,000 and in lymph nodes cells from 14,000 and 72,000. Total numbers of cell subpopulations were calculated based on white blood cell counts and percentages of cells resulting from flow cytometry.
Fig. 1

Gating strategy in flow cytometry for identification of myeloid cells and lymphocyte subpopulations. Representative data from one animal is shown. a Lymphocytes (scattered line) or lymphocytes and myeloid cells together (solid line) were gated according to forward scatter/side scatter properties (FSC/SSC). Dead cells were excluded in a consecutive gate. Live cells were further analysed by three different panels of antibodies (bd, see also Table 2), used to identify various immune cell subpopulations. b Gate 1 CD79α+ cells (B cells); gate 2 CD172 α+ cells (myeloid cells); gate 3 CD3+CD4+ cells (CD4 T cells). c Gate 1 CD3+ cells (total T cells); gate 2 CD3CD8α+ cells (total NK cells); gate 3 (red rectangle): CD3CD8α+NKp46 cells (NK-cell subpopulation); gate 4 (red rectangle): CD3CD8α+NKp46+ cells (NK-cell subpopulation); gate 5 CD3+CD4CD8 α+ (cytolytic T cells). d Gate 1 TCR-γδ+ cells (total γδ T cells); gate 2 (red rectangle): CD2+TCR-γδ+ cells (γδ T-cell subpopulation); gate 3 (red rectangle): CD2TCR-γδ+ cells (γδ T-cell subpopulation); gate 4 CD2+CD8α+CD27+/−TCR-γδ+ cells (γδ T-cell subpopulation)

Cytokine testing by FMIA

The following circulating cytokines/chemokines were determined by applying FMIA on serum samples as described elsewhere [30]: interleukin (IL)-1-beta (IL1β), IL4, IL8, IL10, IL12, interferon gamma (IFNγ) and chemokine ligand (CCL) 2. Used antibodies and standards are listed in Table 3.
Table 3

Standards, capture and detection antibodies used by FMIA

Cytokine (bead region)

Standard

Capture Ab

Detection Ab

IL1β (26)

DY681, part 681-PIa

MAB6811a

BAF 681a

IL4 (34)

CSC1283, part 5S.128.10b

CSC1283, part 5S.128.09b

ASC0849b

IL8 (27)

RP0109S-005c

MCA1660d

MAB5351a

IL12 (36)

912-PLa

MAB9121a

BAM9122a

CCL2 (53)

RP0017S-005c

Anti-poCCL2 clone 5-2e

Anti-poCCL2 clone 18-1e

IFNγ (43)

PPP022d

MP700b

MP701Bb

IL10 (28)

CSC0103, part SD064b

ASC0104b

ASC9109b

aR&D Systems, Minneapolis, MN, USA

bThermo Fisher Scientific, Waltham, MA USA

cKingfisher Biotech, Biomol, Hamburg, Germany

dBio Rad, Hercules, CA, USA

eLunney lab, Beltsville, MD, USA

Statistical evaluation

For statistical analysis laboratory diagnostic findings from samples taken between day 4 and 6 after infection were compared between the groups by Mann–Whitney U test (SPSS Statistics for Windows, Version 20.0, Armonk, NY: IBM Corp.). Differences were assessed to be significant at p ≤ 0.05. Information about results always refers to this time range, unless otherwise stated. Results obtained after day 6 were not statistically evaluated due to small sample numbers.

Results

Comparison of clinical and biochemical alterations in piglets infected with STEC O104:H4 and STEC O157:H7

While animals in the control group stayed healthy, all animals infected with E. coli O104:H4 showed a transient reduction of milk intake. Four pigs out of this group became dehydrated due to diarrhoea starting at day 4 after infection. Two animals developed mild neurological disorders between days 2–6 after infection. Three pigs infected with E. coli O157:H7 developed severe clinical signs and had to be euthanized on days 4 and 5 according to preassigned termination criteria. In two of these pigs, neurological disorders were determined, which were characterised by swaying, incoordination, head shaking and excitation. The third animal was severely dehydrated due to liquid diarrhoea. One animal infected with E. coli O157:H7 survived until the end of trial (day 11 p.i.) but was continuously dehydrated due to diarrhoea. In infected animals, the mean average daily weight gain (ADWG) was 98 g (E. coli O104:H4 infected animals) and 74 g (E. coli O157:H7). ADWG of E. coli O157:H7 infected animals was significantly lower than the ADWG in control animals (115 g, p = 0.034). During necropsy liquid intestinal content was found in the gut of all infected animals. Clinical data are summarized in Table 1.

No differences between groups regarding haematocrit, haemoglobin levels as well as erythrocyte and thrombocyte numbers were found (Table 4). A higher percentage of normoblasts was found early after infection in E. coli O157:H7 infected animals in comparison to control pigs (p = 0.032) and E. coli O104:H4 infected pigs (p = 0.010). One animal infected with E. coli O157:H7 showed thrombocytopenia on day 5 after infection (215 × 109 thrombocytes/l).
Table 4

Laboratory diagnostic findings during the course of infection in blood

  

Negative

E. coli O104:H4

E. coli O157:H7

Median (min–max); number of animal examined

Median (min–max); number of animal examined

Median (min–max); number of animal examined

Time range: reference range

T1

T2

T3

T1

T2

T3

T1

T2

T3

Red blood count

 Haematocrit L/l

0.21–0.37

0.29 (0.24–0.34); 3

0.24 (0.19–0.27); 3

(0.24–0.29); 2

0.25 (0.19–0.35); 6

0.23 (0.21–0.29); 6

0.26 (0.18–0.33); 5

0.22 (0.14–0.31); 4

0.26 (0.23–0.33); 3

0.3; 1

 Haemoglobin g/l

75.0–138.9

95.0 (78.0–112.0); 3

95.9 (79.3–124.0); 3

(72.5–93.8); 2

81.5 (64.0–121.0); 6

87.3 (69.9–116.7); 6

83.2 (60.7–116.3); 5

72.5 (49.0–106.0); 4

78.8 (65.1–97.9); 3

96.8; 1

 Erythrocytes × 1012/l

3.47–6.65

4.02 (3.41–5.10); 3

3.98 (2.69–4.43); 3

(4.29–4.98); 2

3.64 (2.70–5.21); 6

3.79 (3.17–4.55); 6

4.67 (2.61–5.91); 5

3.17 (2.14–4.24); 4

4.86 (3.53–5.92); 3

5.32; 1

 Plateles × 109/l

282–946

62 (21–107); 3

638 (543–910); 3

(571–849); 2

80 (10–229); 6

549 (358–972); 6

925 (580–1180); 5

202 (31–266); 4

723 (215–998); 3

971; 1

 Normoblasts × 1012/l

 

0.09 (0.08–0.13); 3

0.08 (0.06–0.11); 3

(0.00–0.04); 2

0.06 (0.03–0.22); 6

0.05 (0.00–0.15); 6

0.22 (0.00–0.59); 5

0.09 (0.02–0.35); 4

0.33 (0.17–0.38); 3

0.93; 1

Blood chemistry

 Creatinin µmol/l

38–142

95 (84–99); 3

63 (57–67); 3

(51–55); 2

86.5 (55–100); 6

57 (53–73); 6

68 (55–78); 5

103 (86–106); 3

63 (52–72); 4

87; 1

 GLDH U/l

0–11.5

1.0 (0.5–2.0); 3

(0.6–1.4); 2

n.a.

1.3 (0.6–2.1); 5

0.9 (0.1–2.1); 6

0.6 (0.5–2.0); 3

0.7 (0.3–0.9); 3

0.6 (0.2–1.0); 4

0.5; 1

 LDH U/l

409–1549

2013 (1986–2830); 3

1105 (901–1445); 3

(830–1061); 2

1893 (1150–2072); 6

1309 (909–1767); 6

806 (711–1255); 5

1301 (1185–1388); 3

710 (538–804); 4

824; 1

 CK U/l

43–3343

598 (509–850); 3

98 (93–144); 3

(85–195); 2

461 (292–1515); 6

194 (66–296); 6

91 (67–288); 5

303 (241–331); 3

87 (37–111); 4

96; 1

 ASAT U/l

13.7–122.8

36 (36–55); 3

11 (11–22); 3

(12–20); 2

25 (20–36); 5

20 (9–29); 6

14 (11–15); 5

19 (17–26); 3

9 (7–14); 4

11; 1

 Plasma protein g/l

36.65–71.71

19.9 (19.5–22.9); 3

24.8 (23.9–27.8); 3

(27.0–28.5); 2

23.9 (20.9–29.5); 5

28.8 (23.3–31.5); 6

31.2 (27.2–33.1); 5

22.7 (21.9–27.4); 3

30.1 (27.5–30.7); 4

31.4; 1

 Sodium mmol/l

136.0–151.0

130.9 (129.0–132.5); 3

132.6 (130.6–133.4); 3

(129.6–134.5); 2

130.8 (125.8–138.7); 6

133.7 (133.0–137.1); 6

131.7 (130.1–135.2); 5

132.0 (129.9–134.4); 3

132.3 (129.1–135.8); 4

129.5; 1

 Potassium mmol/l

3.78–6.92

4.46 (3.32–4.75); 3

6.59 (5.74–7.60); 3

(5.23–7.04); 2

4.66 (3.99–6.22); 6

5.75 (4.96–6.89); 6

5.79 (5.15–6.12); 5

4.65 (4.44–5.50); 3

5.26 (4.85–5.80); 4

4.97; 1

Acute phase proteins

 Haptoglobin mg/ml

 

(0.03–0.05); 2

0.02 (0.02–0.54); 3

(0.01–0.02); 2

0.04 (0.04–0.06); 3

0.39 (0.04–0.91); 6

0.27 (0.02–1.13); 5

(0.02–0.02); 2

2.62 (2.20–3.00); 4

1.27; 1

 CRP mg/l

 

(<0.05–0.8); 3

3.0 (0.7–13.3); 3

(1.2–3.4); 2

0.7 (<0.05–7.3); 5

7.5 (1.3–203.2); 6

11.0 (<0.05–40.9); 5

(<0.05–1.7); 3

30.0 (9.5–220.1); 4

0.7; 1

 LBP mg/l

 

2.00 (1.00–6.50); 3

2.10 (1.20–4.00); 3

(2.1–4.9); 2

2.80 (0.80–5.10); 5

4.25 (1.70–9.60); 6

4.7 (1.1–8.8); 5

1.20 (1.20–1.30); 3

5.05 (1.20–9.00); 4

7;1

GLDH glutamate dehydrogenase, LDH lactate dehydrogenase, CK creatine kinase, ASAT aspartate transaminase, CRP C-reactive protein, LBP lipopolysaccharide binding protein, n.a. not assessed. T1 timerange 1, preinfectionem, T2 timerange 2, day 4-day 6 p.i., T3 timerange, day 7-day 12 p.i.

Electrolyte and protein concentrations as well as enzyme activities did not differ between the groups. Haptoglobin was significantly increased in E. coli O157:H7 infected pigs compared to negative controls (p = 0.032). CRP and LBP concentrations in infected animals were not significantly increased (Table 4).

Specific weights of urine and other urine parameters did not differ between the groups. All infected piglets showed viable bacteria in the native urine sediments. A selection of results is presented in Table 5.
Table 5

Results gained by urinalysis

Group animal number

Erythrocytes/µl (Combur 9)

Bacteria in urine sediment

Erythrocytes in urine sediment

Squamous epithelial cells

Round epithelial cells

GFR

FE water %

FE Na %

 

T2

T3

T2

T3

T2

T3

T2

T3

T2

T3

T2

T3

T2

T3

T2

T3

Negative

 1

n

n.a.

n

n

n

(+)

(+)

++

(+)

++

3.97

4.9

2.902

4.636

0.165

0.336

 2

250

n.a.

n

n.a.

+

n.a.

+

n.a.

+

n.a.

4.39

4.55

3.851

n.a.

0.029

n.a.

 3

n

n.a.

n

n.a.

+

n.a.

n

n.a.

(+)

n.a.

3.73

n.a.

4.682

n.a.

0.419

n.a.

E. coli O104:H4

 4

n.a.

n

n.a.

+++

n.a.

++

n.a.

+

n.a.

n

4.63

3.68

n.a.

1.945

n.a.

0.23

 5

n.a.

n

n.a.

n.a.

n.a.

+

n.a.

n

n.a.

n

4.24

3.21

n.a.

2.21

n.a.

0.299

 6

250

n.a.

+++

+++

n

n

++

(+)

+

n

3.42

4.03

3.796

3.611

0.034

0.841

 7

n.a.

n

n.a.

++

n.a.

++

n.a.

n

n.a.

n

4.55

4.55

n.a.

3.224

n.a.

0.21

 8

250

n.a.

+

n.a.

n

n.a.

n

n.a.

n

n.a.

4.72

n.a.

n.a.

n.a.

n.a.

n.a.

 9

n

n.a.

+++

n.a.

+

n.a.

+

n.a.

+

n.a.

3.97

3.57

2.856

n.a.

1.061

n.a.

E. coli O157:H7

 10

50

n.a.

++

n.a.

++

n.a.

n

n.a.

n

n.a

4.1

n.a.

1.383

n.a.

0.015

n.a.

 11

n.a.

250

n.a.

+++

n.a.

n

n.a.

n

n.a.

n

4.81

2.87

n.a.

2.024

n.a.

0.341

 12

0

n.a.

++

n.a.

++

n.a.

n

n.a.

n

n.a.

3.85

n.a.

2.565

n.a.

0.026

n.a.

 13

250

n.a.

n

n.a.

+

n.a.

n

n.a.

n

n.a.

3.47

n.a.

2.035

n.a.

0.009

n.a.

n.a. not assessed, n negative, T1 timerange 1, preinfectionem, T2 timerange 2, day 4-day 6 p.i., T3 timerange, day 7-day 12 p.i.

Escherichia coli O157:H7 was reisolated in all infected animals in similar amounts in pure culture. E. coli O104:H4 was reisolated in four animals at all sampling times. In two pigs out of this group (ID 6 and 7) reisolation failed on the day of death. Faeces of all animals within the control group were sterile as expected. In all faeces samples from infected animals Shiga toxin ELISA gave clearly positive results. Findings resulting from bacteriological examinations and ELISA are summarized in Table 1.

Comparison of histopathological and electron microscopical alterations in piglets infected with STEC O104:H4 and STEC O157:H7

Thrombotic microangiopathy in the kidneys was found in two pigs infected with E. coli O157:H7 (Fig. 2) and three pigs infected with E. coli O104:H4. By electron microscopy in a pig infected with E. coli O157:H7, dilation of the subendothelial space within the glomerula with the functional consequence of leakage was seen (Fig. 3d). One animal infected with E. coli 157:H7 showed acute spongiosis, another animal moderate focal liquefaction necrosis in the brainstem (Fig. 4). Histological findings from CNS, kidney and C. ascendens are summarized in Table 6. Results of examination of tissue samples from other organs are not shown, although minor inflammatory alterations in individual piglets were found. Electron microscopy revealed differences in the attachment of the bacteria. While in E. coli O157:H7 infected pigs prominent A/E lesions were found in enterocytes with pedestal formation and deprivation of microvilli (Fig. 3a, c), E. coli O104:H4 stayed in the mucus layer in distance to the epithelium (Fig. 3b).
Fig. 2

Kidney of piglet infected with E. coli O157:H7. Arterial thrombosis (arrow) and severe glomerular hyalinisation (asterisk) are detectable

Fig. 3

Electron microscopic images from E. coli O157:H7 and E. coli O104:H4 infected animals, respectively. a Colon ascendens of piglet infected with E. coli O157:H7. Bacteria are in intimate contact to epithelial cells, causing A/E lesions. Bar = 2500 nm. b Colon ascendens of piglet infected with E. coli O104:H4. Scattered bacteria in mucus above epithelial layer can be seen (arrowheads). No direct contact to epithelial cells is determinable. Bar = 2500 nm. c Colon ascendens of piglet infected with E. coli O157:H7. Bacteria are in intimate contact to epithelial cells, causing A/E lesions. Bar = 500 nm. d Glomerulum of the kidney of an E. coli O157:H7 infected piglet. Dilated subendothelial space caused by detachment of endothelial cells from basement membrane (arrow). Bar = 2500 nm

Fig. 4

Brainstem of a piglet infected with E. coli O157:H7. Liquefaction necrosis: p proliferation of vessels, n neuronal necrosis, g gitter cells (lipid-laden microglia phagocytes)

Table 6

Number of animals with histopathological alterations

 

Negative; n = 3

E. coli O104:H4; n = 6

E. coli O157:H7; n = 4

CNS

 Neuropil vacuolization

3

5

4

 Submeningeal oedema

0

0

1

 Perivascular oedema

1

5

2

 Focal liquefaction necrosis in the brainstem

0

0

1

 Acute white matter spongiosis in cerebellum/brainstem

0

0

1

Kidney

 Thrombosis of renal arterioles

0

3

2

Colon ascendens

 Submucosal oedema

3

4

3

 Subserosal oedema

1

4

2

 Crypt hypoplasia

0

2

0

 Haematoidin/siderin/siderophages

0

2

0

 Lymphoplasmocytic infiltration of the propria

0

2

1

Immune cell subsets in blood and lymph node in piglets infected with STEC O104:H4 and STEC O157:H7

In blood, total number of leukocytes decreased in E. coli O157:H7 infected animals compared to the control group (p = 0.046) and E. coli O104:H4 infected animals (p = 0.020). Two animals infected with E. coli O157:H7 developed leukocytopenia (3.1 and 3.4 G/l, respectively; reference range 3.9–19.7 G/l; [25]). One animal infected with E. coli O104:H4 developed leukocytosis (20.5 G/l).

All pigs infected with E. coli O157:H7 showed low numbers of polymorphonuclear neutrophils (PMN) beneath lower reference value (0.07–1.27; reference range 1.89–11.27 G/l, [25]), one animal infected with E. coli O104:H4 developed granulocytosis (14.56 G/l) (Fig. 5a).
Fig. 5

Frequencies and absolute numbers of various immune cell subsets in E. coli infected and control animals. Dots in scatter plots represent values of individual animals, red lines represent median value within group. Experimental groups are illustrated on the x-axes: 1 control group (n = 3), 2 E. coli O104:H4-infected group (n = 6), 3 E. coli O157:H7-infected group [n = 3 (PBMC), n = 4 (Ln)]. a Absolute number of leukocytes and leukocyte subpopulations obtained by differential counts in white blood cells from day 4 to 6 post infection. bm Absolute number of lymphocyte subpopulations and myeloid cells in blood from day 4 to 6 post infection and percentage of lymphocyte subpopulations within live lymphocytes in lymph node (Ln) on the day of slaughter. b Total T cells (CD3+ phenotype). c Total B cells (CD79α+ phenotype). d Myeloid cells (CD172α+ phenotype). e Total NK cells (CD3CD8α+ phenotype). f NKp46 NK cells (CD3CD8α+NKp46 phenotype). g NKp46+ NK cells (CD3CD8α+NKp46+ phenotype). h CD4+ T cells (CD3+CD4+ phenotype). i Cytolytic T cells (CD3+CD4CD8α+ phenotype). [j Total γδ T cells (TCR-γδ+ phenotype]. j CD2+ γδ T cells (CD2+TCR-γδ+ phenotype). k CD2 γδ T cells (CD2TCR-γδ+ phenotype). l CD2+CD8α+CD27+ γδ T cells (CD2+CD8α+CD27+TCR-γδ+ phenotype)

For the absolute numbers of total T and B cells present in blood in tendency a decrease was found in E. coli infected animals compared to control animals and this decrease was more pronounced in E. coli O157:H7 infected pigs; somehow reflecting the drop of leukocytes counts described above (Fig. 5b, c, respectively). However, within the pool of mesenterial and ileocaecal lymph nodes no obvious change of the percentages of these two lymphocyte subsets was found between the different groups of animals. For CD172 α+ cells (consisting mainly of monocytes after removal of granulocytes by density gradient centrifugation) in blood very heterogeneous numbers were found across all groups (Fig. 5d). In the lymph nodes, percentages of these CD172 α+ myeloid cells were significantly decreased in E. coli O157:H7 (p = 0.034) and E. coli O104:H4 infected animals (p = 0.039) in comparison to control group, respectively.

Next to T and B cells NK cells were addressed as another major lymphocyte subset, including NKp46-defined subsets which have been investigated in pigs previously [31, 32]. Absolute numbers of NK cells and NKp46+ NK cells in blood were slightly enhanced in E. coli O157:H7 infected animals and even more in E. coli O104:H4 infected animals (Fig. 5e, g, respectively). No such changes were found for NKp46 NK cells in blood (Fig. 5f) and no obvious changes were found in NK cells and related NK-cell subsets in lymph nodes (Fig. 5e–g).

In addition to total T cells (CD3+) the subpopulation of CD4+ T cells (CD3+CD4+ phenotype; representing putative T-helper cells) was investigated (Fig. 5h). Similar to the absolute number of total T cells (Fig. 5b) CD4+ T cells were reduced in the blood of infection groups (not significant). In tendency, a slight increase of the percentages of this population was found in the lymph nodes of E. coli O157:H7 infected animals (Fig. 5h). A peculiarity of porcine CD4+ T cells is the up-regulation of CD8α molecules on the cell surface following activation [33]. Hence, within one of the staining panels of our flow cytometry analyses monoclonal antibodies against CD8α were included (Table 2), allowing the investigation of CD8α expression in CD4+ T cells. However, frequencies of CD8α+ CD4+ T cells were extremely low (data not shown), which is in accordance with previously published data of newborn piglets [28]. No obvious changes in absolute counts in blood or frequencies within lymph nodes was found for this very rare T cell subpopulation between infected and control pigs (data not shown). Within the T cell subpopulation of CD3+CD4, CD8α+ cells (representing cytolytic T cells) were analysed (Fig. 5i). In blood of E. coli O157:H7 infected animals total numbers of cytolytic T cells were decreased compared to control pigs and E. coli O104:H4 infected animals. But these differences were not significant. In lymph nodes, percentage of this population was significantly decreased in E. coli O157:H7 infected animals compared to animals infected with E.coli O104:H4 (p = 0.011). γδ T cells are another prominent T cell subpopulation in the blood [34] and secondary lymphatic organs of pigs [35]. For absolute numbers of γδ T cells in blood, a substantial variation among different piglets was found but without an obvious link to E. coli infection (Fig. 5j). Within lymph nodes percentages of γδ T cells were slightly, but not significantly reduced in infection groups. Expression of the cell surface molecules CD2, CD8α and CD27 could be recently related to different stages of γδ T cell development. For CD2 it was shown that already in the thymus two different lineages of γδ T cells can be identified by this marker [36]. For CD8α and CD27 published data suggest that within CD2+ γδ T cells a CD8α+CD27 phenotype is related to a late stage of differentiation [35]. Hence, we analysed expression of CD2, CD8α and CD27 in γδ T cells also in this study (Fig. 5k–m). Absolute numbers in blood for CD2 γδ T cells were slightly increased in E. coli-infected groups (Fig. 5k), whereas CD2+ γδ T cells were slightly reduced (Fig. 5l). No clear infection-related changes were found in the CD2-defined γδ T cell subsets analysed in lymph nodes (Fig. 5j, k). When CD2+ γδ T cells were analysed for CD8α and CD27 expression, the vast majority of cells had a CD8α+CD27+ phenotype (Fig. 5l, m). The absolute numbers of this γδ T cell subset in blood showed no infection-related changes, whereas the percentages of CD8α+CD27+ γδ T cells within CD2+ γδ T cells in lymph nodes was slightly enhanced in infection groups.

Cytokine/chemokine response in piglets infected with STEC O104:H4 and STEC O157:H7

Cytokine/chemokine responses are summarised in Table 7. IFNγ was significantly increased in both infection groups compared to healthy controls (p = 0.038 in E. coli O104:H4 and p = 0.031 in E. coli O157:H7 infected animals, respectively). IL8 in measurable amounts (34.2 pg/ml) could only be found in a single animal infected with E. coli O157:H7 on day 11 after infection (data not shown). IL1β could be measured at very low and comparable levels in all groups. No IL4 response could be measured in any animal (data not shown). IL12 levels were comparably low in all animals, with the exemption of one animal in each infection group (714.l8 pg/ml in an E. coli O104:H4 infected animal and 6247 pg/ml in an E. coli O157:H7 infected animal, respectively). A decrease in CCL2 could be assessed in E. coli O157:H7 infected animals in comparison to the control group (p = 0.034). IL10 was significantly increased in piglets infected with E. coli O104:H4 (p = 0.020) and not significantly increased in E. coli O157:H7 infected animals.
Table 7

Systemic cytokines/chemokines measured in serum of piglets during course of infection using FMIA

 

Negative

E. coli O104:H4

E. coli O157:H7

Median (min–max)

Median (min–max)

Median (min–max)

Time range:

T1, n = 3

T2; n = 3

T3; n = 2

T1; n = 5

T2; n = 6

T3; n = 5

T1; n = 3

T2; n = 4

T3; n = 1

IL1β pg/ml

6.3 (6.3–14.6)

4.7 (3.3–6.5)

5.6 (5.6–5.7)

5.6 (5.0–8.1)

5.6 (4.6–8.4)

5.9 (3.9–7.0)

7.7 (6.7–8.4)

7.5 (5.5–8.9)

8.8

IL12 pg/ml

279.7 (195.0–413.9)

104.0 (101.4–126.9)

2263.4 (106.5–4420.4)

194.9 (152.8–10856.4)

165.9 (91.3–714.8)

91.3 (42.4–139.8)

134.7 (126.9–243.1)

197.1 (93.9–6247.2)

352.5

CCL2 pg/ml

807.1 (730.7–3973.4)

1529.7 (840.6–2935.0)

2550.6 (1751.2–3350.0)

536.4 (251.5–1176.4)

1372.8 (570.1–3598.0)

1917.8 (826.3–4011.7)

603.1 (441.9–672.1)

453.9 (365.4–513.5)

677.3

IFNγ pg/ml

2.8 (0.0–13.6)

0.0 (0.0–16.3)

4.0 (0.0–8.0)

0.0 (0.0–4.2)

38.7 (2.8–582.8)

5.5 (0.0–63.6)

0.0 (0.0–4.2)

48.3 (46.2–98.3)

30.5

IL10 pg/ml

49.4 (45.0–51.5)

11.2 (9.2–15.4)

17.1 (16.7–17.5)

29.5 (22.0–33.1)

20.1 (18.8–30.0)

11.5 (9.8–17.5)

22.7 (22.5–26.2)

19.4 (14.6–31.4)

26.7

T1 timerange 1, preinfectionem, T2 timerange 2, day 4–day 6 p.i., T3 timerange, day 7–day 12 p.i.

Discussion

In this gnotobiotic piglet infection experiment with German LEE-negative E. coli O104:H4 outbreak strain and LEE-positive E. coli O157:H7 main parameters indicative for STEC related disease in humans were analysed. Differences in clinical outcome between the two infection groups were obvious. While three out of four E. coli O157:H7 infected animals developed severe disease and had to be euthanized within 5 days after infection, animals infected with E. coli O104:H4 developed only mild signs of disease with diarrhoea and dehydration as the most consistent clinical signs in this group. In human patients, incubation time of STEC is described to be between 2 and 10 days, with a latency between occurrence of gastrointestinal symptoms and the onset of HUS of approximately 7 days [37, 38]. In the STEC O104:H4 outbreak that struck Germany in 2011 the average incubation time was 8 days with a latency from onset of gastrointestinal symptoms of HUS of approximately 5 days [2]. Thus, it cannot be ruled out that E. coli O104:H4 infected animals in this study would have developed signs of systemic disease, if kept alive longer.

However, due to the restricted space in the isolator units the duration of experiments was limited which was one drawback using this gnotobiotic piglet model. Further drawbacks were the low sample size and that the piglets´ morphological and immunological status of the gut differs from a physiological situation. In the immature gut of neonate piglets infiltration of T-cells and antigen-presenting cells occurs within days after birth, but maturity of the gut is reached not before the sixth week of age [39, 40]. In germ-free animals in general the development of the mucosal immune system is hampered by lack of a physiological colonization with bacterial microflora around birth [39, 40]. This restriction cannot be overcome in the artificial rearing system, which is the main reason for using this model to study systemic responses towards a single pathogenic stimulus. Cell culture models are advantageous for the analysis of specific pathomechanisms on a cellular level. In a model with human IECs the shedding, content and uptake of membrane vesicles of E. coli O104:H4 was demonstrated. In this model a Gb3 and Stx2a-independent mechanism for Stx2a uptake and important pathomechanisms, namely apoptosis of cells by caspase-9 and caspase-3 activation as well as induction of IL8 secretion were shown [6]. Animal models with all their restrictions and cell culture models deliver complementary data. In this gnotobiotic piglet model we found differences in the levels of systemic early immune reactions in combination with clinical, pathological and bacteriological findings.

Bacterial loads in faeces could be evaluated on different days after infection. It was found that both STEC strains colonised the intestine without significant differences in colony counts. Re-isolation failed on the day of necropsy in two animals infected with E. coli O104:H4, but PCR-analysis was positive, so that bacteria might have been killed during sample processing. The question, if the amount of Stx produced in the gut and transferred to the blood stream is different between the strains cannot be answered in this model, but Stx production of both strains in vivo could be confirmed by stool analysis. A method for quantitative determination of Stx2-serum levels is not available so far. The question, why human infections with E. coli O104:H4 in 2011 led to severe clinical outcomes with a high percentage of patients developing HUS and an epidemic course of disease, remains unclear. Disease in piglets caused by this STEC strain did not resemble reported cases in humans, because systemic disease could not be induced. Gnotobiotic piglets seem to be more susceptible to E. coli O157:H7 than to E. coli O104:H4 related disease.

In electron microscopy the different ways of adherence of the tested strains were visible. It can be hypothesised that the mild clinical symptoms in E. coli O104:H4 infected pigs can be attributed to the missing intimate adherence of the strain to enterocytes.

Data about experimentally induced thrombotic microangiopathy (TMA) in piglets infected with STEC are inconsistent. While Francis et al. [41] did not find glomerular damage in E. coli O157:H7 infected piglets, Gunzer et al. [15] found TMA in 5 out of 6 animals infected with E. coli O157:H7 and four animals infected with E. coli O26:H11. In the present trial we could confirm the findings of Gunzer et al. [15]. TMA was present in kidneys from 2 out of 4 piglets infected with E. coli O157:H7 and in 3 out of 6 animals infected with E. coli O104:H4. In a pig infected with E. coli O157:H7 kidney alterations were identified by electron microscopy revealing dilations of subendothelial spaces within glomerula resulting in leakage. Due to the lack of uraemia in the infected piglets, kidney alterations were assessed to be not of impact for organ function. However, other laboratory findings characteristic for HUS in humans could not be observed. In human HUS patients increased numbers of PMN are a negative prognostic marker for the outcome of disease and correlate with severe clinical signs [42]. Granulocytosis could be reproduced in a murine infection model and absence of elevated PMN numbers was correlated to a better clinical outcome [43]. This is in contrast to the findings in this study, as piglets infected with E. coli O157:H7 showed a tendency of lower numbers of PMN and a decrease in total leukocyte cell counts in comparison to the other two groups. The numbers of PMN in pigs infected with E. coli O104:H4 were only slightly increased compared to the control group. The absence of specific alteration of blood parameters indicative for HUS is in accordance to the findings of Gunzer et al. [15]. It can be hypothesised that typical alterations of blood counts do not develop in E. coli O157:H7 infected pigs because of the rapid onset of disease.

Thrombocytopenia can be considered as one of the earliest signs of HUS [44], although not in all human cases thrombocytopenia was observed. Thrombotic microangiopathy without a decrease in thrombocyte numbers was found frequently in humans [45, 46]. Neither in the present study nor in previous studies thrombocytopenia was reproduced in gnotobiotic piglets orally infected with STEC [15]. Age of animals and blood losses after Caesarean section might contribute to the low thrombocyte numbers on the first day of life.

An increase of the enzyme lactate dehydrogenase (LDH) can be observed in most human HUS patients [45]. Neither in this experiment nor in previous trials activities of LDH or other enzymes like glutamate dehydrogenase (GLDH) aspartate transaminase (ASAT), or creatine kinase (CK) were consistently increased in infected pigs [15]. A decrease of the acute phase protein haptoglobin reflects haemolysis, while an increase is indicative for inflammation. In this study haptoglobin concentrations were significantly increased in E. coli O157:H7 infected animals. This can be interpreted as an early sign of inflammation with or without haemolysis. High concentrations of CRP were predictors for neurological complications in E. coli O157:H7 infected human patients [47] and renal insufficiency in persons with TMA [48]. The observed higher concentrations of CRP in individual infected animals are therefore in accordance with literature. One out of three animals with increased CRP concentrations after infection developed neurological disorders. A lack of knowledge in cellular immune reactions during STEC infections and the recent findings about a decisive role of NKT cells for Stx related pathological alterations [11] was initiative for studying different cell populations in different tissues by flow cytometry. In swine NKT cells as defined for mice and humans have not been undoubtedly identified so far, but there are first indications that T cells with NK cell characteristics exist also in swine [49]. NK cells are considered as the first line of defense already in new born animals [28].

No major changes could be found for most of the analysed lymphocyte subpopulations and myeloid cells. Several major lymphocyte subsets in blood followed the observed leukopenia in E. coli O157:H7 infected pigs, namely total (CD79α+) B cells, total (CD3+) T cells and CD4+ (CD3+) T cells. Within mesenterial and ileocaecal lymph nodes, which we assumed to be of relevance due to their anatomical proximity to the gut, only CD172α+ myeloid cells showed a significant reduction in both groups of E. coli infected pigs. The reasons for this are speculative but may indicate a general influx of a mixture of other lymphocytes, since no obvious increase of other investigated lymphocyte subsets was observed. Of note, for CD4+ T cells which are frequently involved in immune responses to bacterial infections, for example via IL17 production [50, 51], no up-regulation of the activation-associated CD8α [33] molecule could be found. This may indicate that the cellular immune system of these newborn piglets is still in a very immature state. In contrast, important immunological effector cells in newborn piglets were the NK cells, which had been found to be perforin positive already at the day of birth, so that an immediate cytotoxic activity of these cells is guaranteed. It was shown previously in piglets that already at birth NKp46 expression on NK cells differed between individuals and that no correlation with environmental factors or age exists [28]. It could not be answered from the results of this study, if NK cells are involved in pathogenesis during STEC infection as shown for NKT cells in mice [11], or if porcine NK cells have a protective effect.

To further address immune responses in STEC infected piglets, we performed FMIA using serum samples. Different cytokines/chemokines were previously determined as parameters for inflammation in HUS-patients in different studies. According to data from the literature we considered levels of cytokines IL1β and IL10 and chemokine IL8 to be of greatest interest in STEC-infection. While IL8 was elevated in D + HUS-patients in comparison to patients with viral or bacterial gastroenteritis, IL10 levels of HUS-patients were decreased [52]. Increased concentrations of IL8 as well as of IL1β in children suffering from acute HUS could also be shown by Inward et al. [53]. In contrast, Litalien et al. [54] found elevated levels of IL10 and unaltered IL8 levels in HUS-patients in comparison to healthy controls. This is in accordance with our findings of an IL10 increase in infected animals and no detectable differences in IL1β or IL8 response between groups. The significantly increased levels of IFNγ in infected groups may be related to the observed higher number of NKp46+ NK cells in blood of these animals. In swine, it has been shown, that NKp46+ NK cells produce more IFNγ than NKp46 NK cells [31].

CCL2, also known as monocyte chemoattractant protein-1 (MCP-1), is assumed to play a role in pathogenesis of HUS by recruitment of monocytes and PMNs to the kidneys [55]. A local role of this chemokine in the urinary tract could not be addressed in our study. Serum concentrations of CCL2 were significantly decreased in piglets infected with E. coli O157:H7.

It seems, that the role of IL4 in swine is different than in mice and humans [56]. Therefore, absence of IL4 response in our study might not reflect the situation in human STEC infections. IL12, which is a link between innate and adaptive immune system and drives immune responses to a T helper 1 response [57] was elevated only in two infected animals.

As bacteriaemia caused by STEC seems to be a rare event and has only been reported in a few cases so far [58, 59], systemic immune response in human patients or infected animals may differ from results gained by cell culture experiments. Thus, divergent results from cytokine/chemokine analyses following exposure to Stx or EHEC in various studies may be explained—at least in part—by different experimental conditions in vivo and ex vivo, and by the kind of biomaterials analysed.

Immunological findings in piglets reported here reveal parameters, which should be further investigated in humans to elucidate pathomechanisms triggered by the hosts’ immune defense during STEC induced disease. In general, the complex data set obtained from animal models can indicate requirements for in-depth systematic analysis of specific mechanisms in vitro. Hence, animal and in vitro models are two options delivering complementary data and should be further exercised.

Conclusions

In this gnotobiotic piglet model, classical EHEC O157:H7 as well as emerging STEC O104:H4 both successfully colonised in the gastrointestinal tract of gnotobiotic piglets. However, differences in the way of bacterial adhesion could be observed in vivo. No systemic disease could be induced by infection with E. coli O104:H4, so that piglets seem to be less susceptible to this pathogen than to E. coli O157:H7, which is in contrast to humans. Immunological findings might suggest the importance of NK cells as early immune effector cells in newborn piglets. Thus, it should be further elucidated, if this cell population plays a key role in HUS pathogenesis.

Abbreviations

A/E: 

attaching and effacing

ADWG: 

average daily weight gain

ASAT: 

aspartate transaminase

CBA: 

Colombia blood agar

CCL: 

chemokine ligand

CFU: 

colony forming unit

CK: 

creatine kinase

CNS: 

central nervous system

CRP: 

C-reactive protein

D + HUS: 

diarrhoea-positive haemolytic uraemic syndrome

E. coli

Escherichia coli

EAEC: 

enteroaggregative Escherichia coli

EHEC: 

enterohemorrhagic Escherichia coli

EPEC: 

enteropathogenic Escherichia coli

ESBL: 

extended-spectrum beta-lactamase

FMIA: 

fluorescent microsphere immunoassays

FSC/SSC: 

forward scatter/side scatter properties

Gb3: 

glycosphingolipid receptor globotriaosylceramide

GLDH: 

glutamate dehydrogenase

HE: 

haematoxylin–eosin

HUSEC: 

Escherichia coli causing haemolytic uraemic syndrome

IEC: 

intestinal epithelial cells

IL: 

interleukin

IL1β: 

IL-1-beta

IFNγ: 

interferon gamma

LBP: 

lipopolysaccharide binding protein

LDH: 

lactate dehydrogenase

LEE: 

locus of enterocyte effacement

LPS: 

lipopolysaccharide

NaCl: 

sodium chloride

NK cells: 

natural killer cells

NKT: 

natural killer T cells

OD: 

optical density

OMV: 

outer membrane vesicles

MCP1: 

monocyte chemoattractant protein-1

PBMC: 

peripheral blood mononuclear cells

PBS: 

phosphate-buffered saline

PMN: 

polymorphonuclear neutrophils

SMAC: 

sorbitol MacConkey agar

STEC: 

Shiga toxin producing Escherichia coli

Stx: 

Shiga toxin

Declarations

Authors’ contributions

BW contributed in organisation and performance of animal trials, analysed data and drafted manuscript. FG participated in study design, the animal trial and provided inocula. He also performed bacteriological diagnostics, interpretation of laboratory diagnostic data and contributed to the draft and revision of the manuscript. WG planned gating strategy in flow cytometry and substantially contributed in analysis of data and drafting of manuscript. HG supervised preparation of samples for histology and electron microscopy. MK performed cell labelling for flow cytometry and contributed in organisation and performance of animal trials. ZB evaluated histological specimens and produced figures. MG performed routine laboratory diagnostic examination of blood and urine. HW and ND performed electron microscopy and produced figures. SMC participated in study design, the animal trial, interpretation of laboratory diagnostic data, and contributed to the draft and revision of the manuscript. AA was in charge of the mother sows and performed Caeseran sections. KHW participated in the design of technical equipment for housing of gnotobiotic piglets. AS participated in study design regarding flow cytometry and drafting of manuscript. KZ participated in study design and interpretation of laboratory diagnostic data. JS and JK isolated STEC O104:H4 strain e2975 in the 2011 outbreak in Germany and coordinated its sequencing and annotation. LKH sequenced STEC O104:H4 outbreak strain e2975. JB assembled and annotated the genome of STEC e2975. RE and IE performed oligonucleotide microarray based geno-serotyping and Stx subtyping of STEC e2975. HPI planned and supervised the study and contributed essentially in performance of animal trials, analysis of data and draft of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank Elke Siever and Fredi Sichau for excellent technical support at preparation and realisation of animal trials. Furthermore, we acknowledge Maria Stadler for initial training on flow cytometry and continuous support during performance of flow cytometry. We thank Stefanie Talker and Hanna Koinig for reading out cells with flow-cytometer and Lisa Reiter for performing FMIA. We also would like to acknowledge Natalie Töpfer, Anja Schubert and Christian Auerbach for preparing bacterial inocula and for analysis of faecal samples. With our best thanks we acknowledge the work of Gudrun Wirth, Barbara Schwert, Petra Röhrig, and Thekla Großmann, who performed laboratory techniques.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

Piglets were housed under sterile and standardised biosafety level 2 conditions according to the regulations of the European Convention concerning the protection of vertebrate animals and followed the Directive of the European Convention for the Protection of Vertebrae Animals used for Experimental and Other Scientific Purposes (European Treaty Series, nos. 123 [60] and 170 [61]) within the legislation for the protection of animals used for scientific purposes [62].

The study was approved from the local permitting authorities in the Lower Saxony State Office for Consumer Protection and Food Safety and in accordance with the requirements of the national animal welfare law (Approval Number: 33.9-42502-04-13/1149) following the guidelines of FELASA and ARRIVE. Precautions aimed at avoiding unnecessary suffering were taken at all stages of the experiment. Pigs were continuously observed during the whole experiment. A humane intervention point (HIP) checklist, which has been developed and approved previously for infection experiments [15] was used while monitoring the animals continuously for clinical signs by trained staff. HIP was conducted by injection of 60 mg pentobarbital/kg body weight (BW) intravenously.

Funding

The study was financed by the Austrian Research Promotion Agency (FFG Bridge project 838502). SMC was supported by the German Research Foundation (DFG CO912/2-1, Research Unit FOR1738) and the Federal Ministry for Education and Research (BMBF 03Z22JN12).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
University Clinic for Swine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine Vienna
(2)
Institute of Medical Microbiology and Hygiene, Faculty of Medicine Carl Gustav Carus, TU Dresden
(3)
Institute of Immunology, Department of Pathobiology, University of Veterinary Medicine Vienna
(4)
Institute of Anatomy, University of Veterinary Medicine Hannover
(5)
Institute for Veterinary Disease Control Mödling, Austrian Agency for Health and Food Safety
(6)
Clinic for Swine, Small Ruminants, Forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover
(7)
Institute for Pathology and Forensic Veterinary Medicine, Department of Pathobiology, University of Veterinary Medicine Vienna
(8)
Department of Anaesthesiology and Intensive Care Medicine, University Hospital Jena
(9)
Centre for Innovation Competence (ZIK) Septomics, University Hospital Jena
(10)
SymbioPharm GmbH
(11)
Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen
(12)
Institute of Cell Biology, Medical Faculty, University Hospital Essen, University of Duisburg-Essen
(13)
Bioinformatics and Systems Biology, Justus-Liebig-University Giessen
(14)
Alere Technologies GmbH

References

  1. Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R. Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr. 1955;85(38–39):905–9.PubMedGoogle Scholar
  2. Frank C, Werber D, Cramer JP, Askar M, Faber M, AnDerHeiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. New Engl J Med. 2011;365(19):1771–80.View ArticlePubMedGoogle Scholar
  3. Bryan A, Youngster I, McAdam AJ. Shiga toxin producing Escherichia coli. Clin Lab Med. 2015;35(2):247–72.View ArticlePubMedGoogle Scholar
  4. Jacewicz MS, Mobassaleh M, Gross SK, Balasubramanian KA, Daniel PF, Raghavan S, McCluer RH, Keusch GT. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J Infect Dis. 1994;169(3):538–46.View ArticlePubMedGoogle Scholar
  5. Kolling GL, Matthews KR. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol. 1999;65(5):1843–8.PubMedPubMed CentralGoogle Scholar
  6. Kunsmann L, Rüter C, Bauwens A, Greune L, Glüder M, Kemper B, Fruth A, Wai SN, He X, Lloubes R. Virulence from vesicles: novel mechanisms of host cell injury by Escherichia coli O104: H4 outbreak strain. Sci Rep. 2015;5:13252.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis. 2011;11(9):671–6.View ArticlePubMedGoogle Scholar
  8. Muniesa M, Hammerl JA, Hertwig S, Appel B, Brussow H. Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol. 2012;78(12):4065–73.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Philipson CW, Bassaganya-Riera J, Hontecillas R. Animal models of enteroaggregative Escherichia coli infection. Gut Microbes. 2013;4(4):281–91.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin C, Iliopoulos D. Origins of the E. coli strain causing an outbreak of hemolytic–uremic syndrome in Germany. N Engl J Med. 2011;365(8):709–17.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Obata F, Subrahmanyam PB, Vozenilek AE, Hippler LM, Jeffers T, Tongsuk M, Tiper I, Saha P, Jandhyala DM, Kolling GL. Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice. Front Microbiol. 2015;6:262.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Siegler RL, Pysher TJ, Tesh VL, Taylor FBJ. Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J Am Soc Nephrol. 2001;12(7):1458–67.PubMedGoogle Scholar
  13. Woods JB, Schmitt CK, Darnell SC, Meysick KC, O’Brien AD. Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli. J Infect Dis. 2002;185(4):550–4.View ArticlePubMedGoogle Scholar
  14. Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang ACK, Kosanke SD, Pysher TJ, Siegler RL. Characterization of the baboon responses to Shiga-like toxin. Descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol. 1999;154(4):1285–99.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Gunzer F, Hennig-Pauka I, Waldmann KH, Sandhoff R, Gröne HJ, Kreipe HH, Matussek A, Mengel M. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli. Am J Clin Pathol. 2002;118(3):364–75.View ArticlePubMedGoogle Scholar
  16. Pohlenz JF, Winter KR, Dean-Nystrom EA. Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome. Infect Immun. 2005;73(1):612–6.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Tzipori S, Montanaro J, Robins-Browne RM, Vial P, Gibson R, Levine MM. Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model. Infect Immun. 1992;60(12):5302–6.PubMedPubMed CentralGoogle Scholar
  18. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA. Illnesses associated with Escherichia coli 0157: H7 infections: a broad clinical spectrum. Ann Intern Med. 1988;109(9):705–12.View ArticlePubMedGoogle Scholar
  19. Geue L, Schares S, Mintel B, Conraths FJ, Müller E, Ehricht R. Rapid microarray-based genotyping of enterohemorrhagic Escherichia coli serotype O156:H25/H-/Hnt isolates from cattle and clonal relationship analysis. Appl Environ Microbiol. 2010;76(16):5510–9.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Geue L, Stieber B, Monecke S, Engelmann I, Gunzer F, Slickers P, Braun SD, Ehricht R. Development of a rapid microarray-based DNA subtyping assay for the alleles of Shiga toxins 1 and 2 of Escherichia coli. J Clin Microbiol. 2014;52(8):2898–904.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Brzuszkiewicz E, Thürmer A, Schuldes J, Leimbach A, Liesegang H, Meyer F, Boelter J, Petersen H, Gottschalk G, Daniel R. Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: entero-aggregative-haemorrhagic Escherichia coli (EAHEC). Arch Microbiol. 2011;193(12):883–91.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104: H4 outbreak by rapid next generation sequencing technology. PLoS ONE. 2011;6(7):e22751.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Tarr PI, Bilge SS, Vary JC Jr, Jelacic S, Habeeb RL, Ward TR, Baylor MR, Besser TE. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect Immun. 2000;68(3):1400–7.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Lavina M, Gaggero C, Moreno F. Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli. J Bacteriol. 1990;172(11):6585–8.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Nerbas E. Aktualisierung von Blutparametern beim Schwein; 2008. http://elib.tiho-hannover.de/dissertations/nerbase_ws08.html. Accessed 13 Feb 2017.
  26. Waldmann KH, Wendt M, Bickhardt K. Creatinine clearance as the foundation for clinical determination of kidney function in swine. Tierarztl Prax. 1991;19(4):373–80.PubMedGoogle Scholar
  27. Hennig-Pauka I, Koch R, Hoeltig D, Gerlach G, Waldmann K, Blecha F, Brauer C, Gasse H. PR-39, a porcine host defence peptide, is prominent in mucosa and lymphatic tissue of the respiratory tract in healthy pigs and pigs infected with Actinobacillus pleuropneumoniae. BMC Res Notes. 2012;5(1):1.View ArticleGoogle Scholar
  28. Talker SC, Käser T, Reutner K, Sedlak C, Mair KH, Koinig H, Graage R, Viehmann M, Klingler E, Ladinig A, Ritzmann M, Saalmüller A, Gerner W. Phenotypic maturation of porcine NK- and T-cell subsets. Dev Comp Immunol. 2013;40(1):51–68.View ArticlePubMedGoogle Scholar
  29. Reutner K, Leitner J, Essler SE, Witter K, Patzl M, Steinberger P, Saalmüller A, Gerner W. Porcine CD27: identification, expression and functional aspects in lymphocyte subsets in swine. Dev Comp Immunol. 2012;38(2):321–31.View ArticlePubMedGoogle Scholar
  30. Ladinig A, Lunney JK, Souza CJ, Ashley C, Plastow G, Harding JC. Cytokine profiles in pregnant gilts experimentally infected with porcine reproductive and respiratory syndrome virus and relationships with viral load and fetal outcome. Vet Res. 2014;45(1):113.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Mair KH, Essler SE, Patzl M, Storset AK, Saalmüller A, Gerner W. NKp46 expression discriminates porcine NK cells with different functional properties. Eur J Immunol. 2012;42(5):1261–71.View ArticlePubMedGoogle Scholar
  32. Mair KH, Müllebner A, Essler SE, Duvigneau JC, Storset AK, Saalmüller A, Gerner W. Porcine CD8α dim/-NKp46 high NK cells are in a highly activated state. Vet Res. 2013;44(1):1.View ArticleGoogle Scholar
  33. Saalmüller A, Werner T, Fachinger V. T-helper cells from naive to committed. Vet Immunol Immunopathol. 2002;87(3):137–45.View ArticlePubMedGoogle Scholar
  34. Takamatsu H, Denyer M, Stirling C, Cox S, Aggarwal N, Dash P, Wileman T, Barnett P. Porcine γδ T cells: possible roles on the innate and adaptive immune responses following virus infection. Vet Immunol Immunopathol. 2006;112(1):49–61.View ArticlePubMedGoogle Scholar
  35. Sedlak C, Patzl M, Saalmüller A, Gerner W. IL-12 and IL-18 induce interferon-γ production and de novo CD2 expression in porcine γδ T cells. Dev Comp Immunol. 2014;47(1):115–22.View ArticlePubMedGoogle Scholar
  36. Stepanova K, Sinkora M. Porcine γδ T lymphocytes can be categorized into two functionally and developmentally distinct subsets according to expression of CD2 and level of TCR. J Immunol. 2013;190(5):2111–20.View ArticlePubMedGoogle Scholar
  37. Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, Bartleson CA, Lewis JH, Barrett TJ, Wells JG. A multistate outbreak of Escherichia coli o157: h7—associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington experience. JAMA. 1994;272(17):1349–53.View ArticlePubMedGoogle Scholar
  38. Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet. 1998;352(9135):1207–12.View ArticlePubMedGoogle Scholar
  39. Bailey M, Haverson K, Inman C, Harris C, Jones P, Corfield G, Miller B, Stokes C. The development of the mucosal immune system pre-and post-weaning: balancing regulatory and effector function. Proc Nutr Soc. 2005;64(04):451–7.View ArticlePubMedGoogle Scholar
  40. Rothkötter H, Ulbrich H, Pabst R. The postnatal development of gut lamina propria lymphocytes: number, proliferation, and T and B cell subsets in conventional and germ-free pigs. Pediatr Res. 1991;29(3):237–42.View ArticlePubMedGoogle Scholar
  41. Francis DH, Moxley RA, Andraos CY. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect Immun. 1989;57(4):1339–42.PubMedPubMed CentralGoogle Scholar
  42. Exeni RA, Fernandez GC, Palermo MS. Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome. Sci World J. 2007;7:1155–64.View ArticleGoogle Scholar
  43. Fernandez G, Lopez M, Gomez S, Ramos M, Bentancor L, Fernandez-Brando R, Landoni V, Dran G, Meiss R, Isturiz M. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol. 2006;146(1):76–84.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073–86.PubMedGoogle Scholar
  45. De Serres SA, Isenring P. Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria. Nephrol Dial Transplant. 2009;24(3):1048–50.View ArticlePubMedGoogle Scholar
  46. Sallée M, Ismail K, Fakhouri F, Vacher-Coponat H, Moussi-Francés J, Frémaux-Bacchi V, Burtey S. Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome. BMC Nephrol. 2013;14(1):1.View ArticleGoogle Scholar
  47. Teramoto T, Fukao T, Hirayama K, Asano T, Aoki Y, Kondo N. Escherichia coli O-157-induced hemolytic uremic syndrome: usefulness of SCWP score for the prediction of neurological complication. Pediatr Int. 2009;51(1):107–9.View ArticlePubMedGoogle Scholar
  48. Dierkes F, Andriopoulos N, Sucker C, Kuhr K, Hollenbeck M, Hetzel GR, Burst V, Teschner S, Rump LC, Benzing T. Indicators of acute and persistent renal damage in adult thrombotic microangiopathy. PLoS ONE. 2012;7(1):e30886.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Talker SC, Stadler M, Koinig HC, Mair KH, Rodriguez-Gomez IM, Graage R, Zell R, Durrwald R, Starick E, Harder T, Weissenböck H, Lamp B, Hammer SE, Ladinig A, Saalmüller A, Gerner W. Influenza A virus infection in pigs attracts multifunctional and cross-reactive T cells to the lung. J Virol. 2016;90(20):9364–82.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Bedoui S, Kupz A, Wijburg OL, Walduck AK, Rescigno M, Strugnell RA. Different bacterial pathogens, different strategies, yet the aim is the same: evasion of intestinal dendritic cell recognition. J Immunol. 2010;184(5):2237–42.View ArticlePubMedGoogle Scholar
  51. McGeachy MJ. Th17 memory cells: live long and proliferate. J Leukoc Biol. 2013;94(5):921–6.View ArticlePubMedGoogle Scholar
  52. Westerholt S, Hartung T, Tollens M, Güstrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R. Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis—pathophysiological and diagnostic clues. Cytokine. 2000;12(6):822–7.View ArticlePubMedGoogle Scholar
  53. Inward CD, Varagunam M, Adu D, Milford DV, Taylor CM. Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection. Arch Dis Child. 1997;77(2):145–7.View ArticlePubMedPubMed CentralGoogle Scholar
  54. Litalien C, Proulx F, Mariscalco MM, Robitaille P, Turgeon JP, Orrbine E, Rowe PC, McLaine PN, Seidman E. Circulating inflammatory cytokine levels in hemolytic uremic syndrome. Pediatr Nephrol. 1999;13(9):840–5.View ArticlePubMedGoogle Scholar
  55. Van Setten PA, Van Hinsbergh VW, Van Den Heuvel LP, Lambertus PWJ, Preyers F, Dijkman HB, Assmann KJ, Van Der Velden TJ, Monnens LA. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res. 1998;43(6):759–67.View ArticlePubMedGoogle Scholar
  56. Murtaugh MP, Johnson CR, Xiao Z, Scamurra RW, Zhou Y. Species specialization in cytokine biology: is interleukin-4 central to the T H 1–T H 2 paradigm in swine? Dev Comp Immunol. 2009;33(3):344–52.View ArticlePubMedGoogle Scholar
  57. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev. 1997;10(4):611–36.PubMedPubMed CentralGoogle Scholar
  58. Buvens G, De Rauw K, Roisin S, Vanfraechem G, Denis O, Jacobs F, Scheutz F, Pierard D. Verocytotoxin-producing Escherichia coli O128ab:H2 bacteremia in a 27-year-old male with hemolytic-uremic syndrome. J Clin Microbiol. 2013;51(5):1633–5.View ArticlePubMedPubMed CentralGoogle Scholar
  59. Lienemann T, Salo E, Rimhanen-Finne R, Rönnholm K, Taimisto M, Hirvonen JJ, Tarkka E, Kuusi M, Siitonen A. Shiga Toxin–producing Escherichia coli serotype O78: H–in Family, Finland, 2009. Emerg Infect Dis. 2012;18(4):577–81.View ArticlePubMedPubMed CentralGoogle Scholar
  60. European Convention concerning the protection of vertebrate animals and followed the Directive of the European Convention for the Protection of Vertebrae Animals Used for Experimental and Other Scientific Purposes (European Treaty Series, nos. 123. http://conventions.coe.int/treaty/EN/treaties/html/123.htm. Accessed 13 Feb 2017.
  61. European Convention concerning the protection of vertebrate animals and followed the Directive of the European Convention for the Protection of Vertebrae Animals Used for Experimental and Other Scientific Purposes (European Treaty Series, nos. 170. http://conventions.coe.int/treaty/EN/treaties/html/170.htm. Accessed 13 Feb 2017.
  62. Animals used for scientific purposes. http://ec.europa.eu/environment/chemicals/lab_animals/home_en.htm. Accessed 13 Feb 2017.

Copyright

© The Author(s) 2017